Table 5: Comparison of observed events with predicted events (N = 78).
| Events (per 100 patients/year)* | Observed | Predicted | Reduction | p-value |
| Death | 19 (9.1%) | |||
| Severe/significant bleeding | 14 (6.7%) | 7.7% (HAS-BLED) | (-13%) | 0.389 |
| Stroke | 5 (2.4%) | 10.0% (CHADS2)
(-73%) |
5.9%
(-59%) |
< 0.001 |
| 9.0% (CHA2DS2-VASc)
(-76%) |
6.7%
(-64%) |
< 0.001 |
*Overall follow-up: 32.2 months (209 patients/year).